A panel has ruled that pharmaceutical companies are not required to disclose drug prices in TV ads; the World Health Organization (WHO) halted its study of hydroxychloroquine to treat coronavirus disease 2019; Oklahoma officials warn medically vulnerable individuals to stay home from President Trump’s rally this weekend.
A Washington, DC, panel blocked a rule forcing drug makers to display drug prices in television advertisements, Court House News reports. The panel ruled unanimously to uphold a federal judge’s decision striking down the Trump administration’s rule, which was challenged by pharmaceutical companies including Merck, Eli Lilly, and Amgen. The rule would have required disclosure of medication list prices covered by Medicare or Medicaid that cost above $35 for a 1-month supply, in an effort to drive down drug prices. However, the judges argued the price ultimately included in the advertisement would bear little resemblance to what beneficiaries actually pay.
The World Health Organization (WHO) announced it would halt testing of the malaria drug hydroxychloroquine in the Solidarity Trial, a multicountry study investigating treatments for coronavirus disease 2019 (COVID-19), Reuters reports. The announcement comes after new data show the drug did not reduce mortality in patients with COVID-19, including data from the Solidarity Trial itself. Specifically, the trial will no longer recruit patients to the hydroxychloroquine arm, but patients who were previously administered the drug will finish their course or stop based on a supervisor’s discretion. The FDA revoked its emergency use authorization for the drug on June 15.
Officials in Tulsa, Oklahoma, are warning medically vulnerable populations (those over 60 or with compromised immune systems) to stay home from President Trump’s rally scheduled for Saturday, June 20, according to The Hill. The state continues to see a surge in COVID-19 cases and hospitalizations, while Tulsa Health Department Director Bruce Dart and Mayor G.T. Bynum caution any individuals attending large gatherings will likely be at risk for contracting the disease. The Trump campaign plans to conduct a temperature check on each attendee and offer hand sanitizer and masks at the door, but wearing masks is not required in the 20,000-seat arena. In addition, all attendees must sign a waiver promising not to sue the Trump campaign or venue should they contract COVID-19.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
FDA Approves Ravulizumab-cwvz for Rare Autoimmune Disease
March 28th 2024Ravulizumab-cwvz (Ultomiris) received a label expansion by the FDA for the treatment of adult neuromyelitis optica spectrum disorder in patients with anti–aquaporin-4 antibodies after trials results showed it could prevent relapses.
Read More
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More